Aviva
EXAS

Aviva’s Exact Sciences EXAS Stock Holding History

Aviva’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-120,275
Closed -$5.21M – 891
2025
Q1 		$5.21M Buy
120,275
+16,624
+16% +$842K 0.01% 533
2024
Q4 		$5.82M Buy
+103,651
New +$6.45M 0.02% 516
2024
Q3 		– Sell
-13,684
Closed -$578K – 906
2024
Q2 		$578K Buy
13,684
+6,844
+100% +$377K ﹤0.01% 811
2024
Q1 		$472K Sell
6,840
-30,080
-81% -$1.9M ﹤0.01% 871
2023
Q4 		$2.73M Sell
36,920
-70,134
-66% -$4.6M 0.01% 565
2023
Q3 		$7.3M Buy
107,054
+84,888
+383% +$7.2M 0.03% 464
2023
Q2 		$2.08M Buy
22,166
+2,168
+11% +$169K 0.01% 618
2023
Q1 		$1.36M Sell
19,998
-4,020
-17% -$258K 0.01% 817
2022
Q4 		$1.19M Sell
24,018
-247
-1% -$10.1K 0.01% 769
2022
Q3 		$788K Sell
24,265
-30,033
-55% -$1.24M ﹤0.01% 927
2022
Q2 		$2.14M Sell
54,298
-1,432
-3% -$76.6K 0.01% 766
2022
Q1 		$3.9M Buy
55,730
+668
+1% +$48.8K 0.02% 642
2021
Q4 		$4.29M Buy
55,062
+2,763
+5% +$244K 0.02% 629
2021
Q3 		$4.99M Sell
52,299
-2,646
-5% -$279K 0.02% 579
2021
Q2 		$6.83M Buy
54,945
+5,668
+12% +$676K 0.03% 498
2021
Q1 		$6.49M Buy
49,277
+40
+0.1% +$5.47K 0.03% 455
2020
Q4 		$6.52M Buy
49,237
+1,167
+2% +$141K 0.03% 426
2020
Q3 		$4.9M Sell
48,070
-1,136
-2% -$98.1K 0.03% 456
2020
Q2 		$4.28M Sell
49,206
-37
-0.1% -$2.96K 0.03% 459
2020
Q1 		$2.86M Buy
49,243
+415
+0.8% +$33.7K 0.02% 665
2019
Q4 		$4.52M Buy
48,828
+5,367
+12% +$472K 0.03% 494
2019
Q3 		$3.93M Buy
+43,461
New +$4.95M 0.03% 490

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Aviva's EXAS Position: Q2 2025 in Review

Aviva sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 120,275 shares — an estimated $5.21M sold.

Aviva first reported a position in EXAS in Q3 2019 and held it in 22 quarters. The position peaked at $7.3M in Q3 2023. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Aviva reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Aviva sold 120,275 Exact Sciences shares in Q2 2025, an estimated $5.21M.
  • Aviva first reported a position in Exact Sciences in Q3 2019 and held it in 22 quarters.
  • Aviva's Exact Sciences position peaked at $7.3M in Q3 2023.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Aviva's 13F filing for Q2 2025, filed 7 Aug 2025.